Long-acting β-agonist monotherapy among children and adults with asthma

American Journal of Managed Care

Volumn 17, Issue 4, 2011, Pages

  Wasilevich, Elizabeth A ^a   Clark, Sarah J ^a   Cohn, Lisa M ^a   Dombkowski, Kevin J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMOTEROL FUMARATE; SALMETEROL;

ADULT; AMBULATORY CARE; ARTICLE; ASTHMA; CHILD; CLINICAL ASSESSMENT; DRUG USE; ETHNICITY; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HUMAN; MALE; MEDICAID; MONOTHERAPY; PATIENT EDUCATION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADULT; AGE DISTRIBUTION; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; DRUG PRESCRIPTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MEDICAID; MICHIGAN; PHYSICIAN'S PRACTICE PATTERNS; POPULATION SURVEILLANCE; PREVALENCE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; UNITED STATES;

EID: 79960228540     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma: summary report 2007. J Allergy Clin Immunol. 2007;120(5)(suppl):S94-S138.
2. Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting b-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med. 2006;144(12):904-912. (Pubitemid 46768131)
3. 2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA. 2001;285(20):2583-2593.
4. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM; SMART Study Group. The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol [published correction appears in Chest. 2006;129(5):1393]. Chest. 2006;129(1):15-26.
5. Castle W, Fuller R, Hall J, Palmer J. Serevent Nationwide Surveillance Study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ. 1993;306(6884):1034-1037. (Pubitemid 23105961)
6. Levinson M. Long-acting β-agonists and adverse asthma events meta-analysis: statistical briefing package for joint meeting of the Pulmonary-Allergy Drugs Advisory Committee, Drug Safety and Risk Management Advisory Committee and Pediatric Advisory Committee on December 10-11, 2008. http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4398b1-01-FDA.pdf. Accessed June 3, 2010.
7. Seymour S. Long-acting β-agonists: background and regulatory history. 2008. http://www.fda.gov/ohrms/dockets/ac/08/slides/2008-4398s1-02- Seymour-files/frame.htm. Accessed June 3, 2010.
8. U.S. Food and Drug Administration. FDA drug safety communication: drug labels now contain updated recommendations on the appropriate use of long-acting inhaled asthma medications called long-acting β-agonists (LABAs). 2010. http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm213836.htm. Accessed June 3, 2010.
9. U.S. Food and Drug Administration. Long-acting β-agonists (LABAs): new safe use requirements. 2010. http://www.fda.gov/Safety/Med-Watch/ SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm201003.htm. Accessed April 29, 2010.
10. National Committee for Quality Assurance. HEDIS (Healthcare Effectiveness Data and Information Set) & quality measurement. 2007. http://web.ncqa.org/ tabid/59/Default.aspx. Accessed August 31, 2007.
11. Friedman H, Wilcox T, Reardon G, Crespi S, Yawn BP. A retrospective study of the use of fluticasone propionate/salmeterol combination as initial asthma controller therapy in a commercially insured population. Clin Ther. 2008;30(10):1908-1917.
12. Kattan M, Crain EF, Steinbach S, et al. A randomized clinical trial of clinician feedback to improve quality of care for inner-city children with asthma. Pediatrics. 2006;117(6):e1095-e1103. (Pubitemid 46071204)
13. Dombkowski KJ, Harrison SR, Cohn LM, Lewis TC, Clark SJ. Continuity of prescribers of short-acting β-agonists among children with asthma. J Pediatr. 2009;155(6):788-794.